NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Inventory discrepancies toy with Zuru’s NZ accounts
Retail

Inventory discrepancies toy with Zuru’s NZ accounts

Zuru NZ's accounts are filed, but there are caveats.

Denise McNabb 17 Jun 2025
MyFarm's solar seduction
Primary Sector Analysis

MyFarm's solar seduction

What does an investor need to believe about this 10-12% p.a. offer?

Pattrick Smellie 16 Jun 2025
The future of coastal shipping in New Zealand
Infrastructure Blue Highway

The future of coastal shipping in New Zealand

It's greener and usually cheaper, so why isn't domestic coastal shipping thriving?

Oliver Lewis 16 Jun 2025
My Net Worth: Chris Bishop, Cabinet minister
Editor's Picks

My Net Worth: Chris Bishop, Cabinet minister

Bishop on being a bit of a bogan, black nail polish and politics. 

Oliver Lewis 15 Jun 2025